High biocompatibility can be bad for IOL (intraocular lens) implants
This article was originally published in Clinica
Certain types of intraocular lens (IOL) implants can be too biocompatible and lead to cell build up that causes a clouding of the device. These findings were reported by UK researchers in the latest issue of Archives of Ophthalmology.
You may also be interested in...
Previous businesses FDA warned about COVID-19 claims for chlorine dioxide, a bleach solution, were marketing dietary supplements unlawfully. But Pro Breath MD's oral rinses available under the Dentist Select and OraCare brands are allowed and FDA isn’t asking the firm to discontinue distribution.
The Stark Law ban on self-referrals wouldn’t apply to some physician owners of advanced imaging facilities under a CMS final rule.
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.